DG Health Sinus Severe nasal decongestant recalled for contaminated excipient
Perrigo Company is recalling DG Health Sinus Severe nasal decongestant because the product was manufactured with a contaminated excipient that was recalled from the supplier. Three batches are affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. No illnesses, injuries, or hospitalizations are reported in the source text. The hazard is a manufacturing process deviation (contaminated excipient) rather than a confirmed harmful substance, making this a precautionary recall.
Plain-English summary
Perrigo Company PLC is recalling DG Health Sinus Severe (Oxymetazoline Hydrochloride 0.05% Nasal Decongestant with Menthol), a non-prescription nasal decongestant sold in 1 FL Oz bottles. The recall affects three batches: 1BK0931 (expiration 12/31/2022), 1CK0900 (expiration 01/31/2023), and 1HK1196 (expiration 02/28/2023).
The product is being recalled because it was manufactured using a contaminated excipient that was itself recalled by the supplier.
The product was distributed nationwide in the USA. Consumers who have purchased affected batches should stop using the product and consult their healthcare provider or poison control if they have questions or concerns about their use.
The recalled product
- Product
- DG HEALTH SINUS SEVERE (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- DG HEALTH SINUS SEVERE
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — OTC Nasal Decongestant
- Affected units
- 79,776
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Batch: 1BK0931
- Exp 12/31/2022
- 1CK0900
- Exp 01/31/2023
- 1HK1196
- Exp 02/28/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 51 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · contaminated excipient
See all →- ModerateEquate Children's Pain and Fever recalled due to contaminated excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Infant Pain and Fever Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
Similar recalls
- SeverePerrigo Recalls Zephrex-D Nasal Decongestant Due to Microbial Contamination
FDA (Drugs) · 2017-12-27
- ModerateNasal Decongestant Recalled for Possible Manufacturing Water Contamination
FDA (Drugs) · 2024-01-10
- CriticalCVS Sinus Relief Nasal Spray Recalled for Pseudomonas Contamination
FDA (Drugs) · 2018-10-24
- ModerateOTC Nasal Decongestant Recalled Due to Manufacturing Process Deviation
FDA (Drugs) · 2024-01-10
- ModerateWalgreens Severe Anefrin Nasal Spray Recalled for Quality Deviations
FDA (Drugs) · 2018-10-24
- ModerateFDA Recalls Premier Value Nasal Spray Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-24